Resilience Care Targets Between-Visit Oncology Care With Continuous Monitoring

According to a recent LinkedIn post from Resilience Care, the company is emphasizing the clinical and operational risks community oncology practices face in the periods between patient visits. The post suggests that most cancer patients have limited in-person time with care teams, leaving practices with limited visibility into patient status for the majority of the month.

The post highlights that Resilience Care works with oncology practices to provide continuous between-visit monitoring, early warning detection, and structured clinical triage. This model is presented as a way to intervene before unmanaged symptoms escalate into emergency room visits or treatment disruptions, which may have implications for both patient outcomes and practice economics.

As shared in the LinkedIn post, Resilience Care plans to engage with practice leaders at the 2026 Community Oncology Conference in Orlando, Florida, where it will be present at Booth 601. For investors, this presence at an industry conference could indicate a focus on business development and market penetration within community oncology, potentially supporting future growth if the company gains traction with additional practice partners.